Fundraising FoxOncosec Medical
San Diego, US · Nevada corporation
Find your way into Oncosec Medical
Sign up to see every warm intro you have to Oncosec Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncosec Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PD
Punit DhillonFounder
DO
Daniel O'ConnorNamed on SEC filing
AD
Avtar DhillonNamed on SEC filing
Board
AM
Anthony MaidaBoard director
JD
James DeMesaBoard director
AJ
Annalisa JenkinsBoard director
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 2 of 4 rounds · 2017–2023
▶Undisclosed amountofferedMay 2023 · 7 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMay 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chao ZhouDirector
- Linda ShiDirector
- Robert H. ArchExecutive Officer, Director
- George ChiExecutive Officer
- Stephany FosterDirector
- Joon KimDirector
- Herbert Kim LyerlyDirector
- Kevin R SmithDirector
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶Undisclosed amountofferedApr 2023 · 7 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedApr 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Herbert Kim LyerlyDirector
- Linda ShiDirector
- Chao ZhouDirector
- Joon KimDirector
- Stephany FosterDirector
- Robert H. ArchExecutive Officer, Director
- Kevin R SmithDirector
- George ChiExecutive Officer
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Apr 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5.7MraisedNov 2017 · 9 investors · BiotechnologyRule 506(b)
▶$5.7MraisedNov 2017 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Punit DhillonExecutive Officer, Director
- Avtar DhillonDirector
- Anthony MaidaDirector
- Annalisa JenkinsDirector
- Daniel O'ConnorExecutive Officer, Director
- Richard SlanskyExecutive Officer
- James DeMesaDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- Sales commissions
- $78.3K
- Placement agents
- H.C WAINWRIGHT & CO., LLC
- First sale
- Nov 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$4.9MraisedNov 2017 · 9 investors · BiotechnologyRule 506(b)
▶$4.9MraisedNov 2017 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony MaidaDirector
- Richard SlanskyExecutive Officer
- James DeMesaDirector
- Daniel O'ConnorDirector
- Annalisa JenkinsDirector
- Avtar DhillonDirector
- Punit DhillonExecutive Officer, Director
- Offering amount
- $4.9M
- Amount sold
- $4.9M
- Sales commissions
- $389.6K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Oncosec Medical?
- Oncosec Medical was founded by Punit Dhillon.
- How much funding has Oncosec Medical raised?
- Oncosec Medical has disclosed $10.6M raised across 2 of its 4 known rounds.
- Where is Oncosec Medical headquartered?
- Oncosec Medical is headquartered in San Diego, US.